T2 Biosystems, Inc. (TTOO)

Market Cap	84.14K -98.7%
Revenue (ttm)	7.68M -30.2%
Net Income	-42.95M
EPS	-4.08
Shares Out	28.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35
Average Volume	12,241
Open	0.0115
Previous Close	0.0030
Day's Range	0.0030 - 0.0115
52-Week Range	0.0001 - 0.1800
Beta	0.88
RSI	50.06
Earnings Date	Feb 13, 2026

About T2 Biosystems

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 113
• Stock Exchange: OTCMKTS
• Ticker Symbol: TTOO

Financial Performance

In 2023, T2 Biosystems's revenue was $7.19 million, a decrease of -67.75% compared to the previous year's $22.31 million. Losses were -$50.08 million, -19.66% less than in 2022.